Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)

NCT03268603 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

ALS
Amyotrophic Lateral Sclerosis

Interventions

DRUG: Autologous Adipose-derived Mesenchymal Stromal Cells

Sponsor

Mayo Clinic

Collaborators

[object Object]